
Medicines Discovery Catapult
Medicines Discovery Catapult
4 Projects, page 1 of 1
assignment_turned_in Project2021 - 2024Partners:University of Strathclyde, UK-CPI (dup'e), Medicines Discovery Catapult, LGC, Medicines Discovery Catapult +4 partnersUniversity of Strathclyde,UK-CPI (dup'e),Medicines Discovery Catapult,LGC,Medicines Discovery Catapult,LGC Ltd,Medicines Discovery Catapault,University of Strathclyde,UK-CPIFunder: UK Research and Innovation Project Code: EP/V028960/1Funder Contribution: 853,129 GBPThe bespoke Multiscale Metrology Suite, will combine powerful leading-edge detectors for measuring nanomaterial properties and transform the measurement of health nanotechnologies. We will build a modular system combining the latest in flow field fractionation technologies with mass spectrometry, Raman and light scattering detectors for the physical and chemical measurement of nanomaterial properties. The requested equipment will enable world-leading researchers at the University of Strathclyde, other UK academic institutions, and industry to accelerate their research into new technologies for healthcare applications and remain competitive in the global race for delivering new innovations in health. Moreover, this equipment will generate new research avenues and partnership opportunities that will create a step-change in the physical and chemical analytical capability and infrastructure for UK health nanotechnology research. This leading-edge suite will ultimately reduce the time and costs associated with delivering new diagnostics and drug treatments, improving quality of life and delivering much needed lifesaving drugs to patients. Strong partnerships with industry partners and government facilities will ensure that this national facility will remain globally-competitive and deliver innovations.
more_vert assignment_turned_in Project2022 - 2024Partners:Medicines Discovery Catapult, Medicines Discovery Catapault, University of Ghana, NOVABIOTICS LTD, NTU +4 partnersMedicines Discovery Catapult,Medicines Discovery Catapault,University of Ghana,NOVABIOTICS LTD,NTU,Medicines Discovery Catapult,Novabiotics Ltd,University of Ghana,University of NottinghamFunder: UK Research and Innovation Project Code: BB/W018497/1Funder Contribution: 10,081 GBPGhana
more_vert assignment_turned_in Project2019 - 2028Partners:Biotronics 3D Ltd, Lightpoint Medical Ltd, AstraZeneca plc, Ultromics Ltd, UNIL +81 partnersBiotronics 3D Ltd,Lightpoint Medical Ltd,AstraZeneca plc,Ultromics Ltd,UNIL,Perspectum Diagnostics,Ultromics Ltd,THERS,GE Aviation,GE Healthcare,NVIDIA Limited,Radiologics Inc,Stanford Synchroton Radiation Laboratory,German Cancer Research Centre,South London and Maudsley NHS Trust,Brigham and Women's Hospital,Graduiertenkolleg BIOQIC,quibim,Nagoya University,Image Analysis Ltd (UK),Siemens Healthineers,HeartFlow Inc.,Medicines Discovery Catapult,Massachusetts General Hospital East,GSTT NIHR Biomedical Research Centre,Brigham and Women's Hospital,Medicines Discovery Catapault,Medicines Discovery Catapult,Siemens AG,PHILIPS MEDICAL SYSTEMS NEDERLAND BV,icoMetrix,Mirada Medical UK,Theragnostics Ltd,GlaxoSmithKline PLC,University of Copenhagen,Imanova Limited,IMANOVA LIMITED,Graduiertenkolleg BIOQIC,Xtronics Ltd.,Brainminer,NIHR Imperial Biomedical Research Centre,National Institute for Health Research,Philips (Netherlands),University of Copenhagen,NVIDIA Limited (UK),Xtronics Ltd.,Optellum Ltd,TheraPanacea,QUIBIM,Image Analysis Group,MR Code BV,GSK,Theragnostics Ltd,AKH,SU,NIHR Imperial Biomedical Research Centre,Radiologics,Biotronics 3D Ltd,King's College Hospital Charitable Trust,Optellum Ltd,Stanford University,Therapanacea,Massachusetts Institute of Technology,Memorial Sloan- Kettering Cancer Centre,Massachusetts Institute of Technology,GSTT NIHR Biomedical Research Centre,Memorial Sloan- Kettering Cancer Centre,HKU,King's College Hospital NHS Foundn Trust,Perspectum Diagnostics,HeartFlow Inc.,Massachusetts General Hospital East,German Cancer Research Center,Astrazeneca,MIT,GE Healthcare,Brainminer,Mirada Medical UK,ASTRAZENECA UK LIMITED,icometrix,MR Code BV,NIHR Imperial Biomedical Research Centre,GlaxoSmithKline (Harlow),Lightpoint Medical Ltd,PHILIPS MEDICAL SYSTEMS NEDERLAND,KCLFunder: UK Research and Innovation Project Code: EP/S022104/1Funder Contribution: 6,339,630 GBPMedical imaging has made major contributions to healthcare, by providing noninvasive diagnostics, guidance, and unparalleled monitoring of treatment and understanding of disease. A suite of multimodal imaging modalities is nowadays available, and scanner hardware technology continues to advance, with high-field, hybrid, real-time and hand-held imaging further pushing on technological boundaries; furthermore, new developments of contrast agents and radioactive tracers open exciting new avenues in designing more targeted molecular imaging probes. Conventionally, the individual imaging components of probes and contrast mechanisms, acquisition and reconstruction, and analysis and interpretation are addressed separately. This however, is creating unnecessary silos between otherwise highly synergistic disciplines, which our current EPSRC CDT in Medical Imaging at King's College London and Imperial College London has already started to successfully challenge. Our new CDT will push this even further by bridging the different imaging disciplines and clinical applications, with the interdisciplinary research based on complementary collaborations and new research directions that would not have been possible five years ago. Through a comprehensive, integrated training programme in Smart Medical Imaging we will train the next generation of medical imaging researchers that is needed to reach the full potential of medical imaging through so-called "smart" imaging technologies. To achieve this ambitious goal we have developed four new Scientific Themes which are synergistically interlinked: AI-enabled Imaging, Smart Imaging Probes, Emerging Imaging and Affordable Imaging. This is complemented by a dedicated 1+3 training programme, with a new MRes in Healthcare Technologies at King's as the foundation year, strong industry links in form of industry placements, careers mentoring and workshops, entrepreneurship training, and opportunities in engaging with international training programmes and academic labs to become part of a wider cohort. Cohort building, Responsible Research & Innovation, Equality, Diversity & Inclusion, and Public Engagement will be firmly embedded in this programme. Students graduating from this CDT will have acquired a broad set of scientific and transferable skills that will enable them to work across the different medical imaging sub-disciplines, gaining a high employability over wider sectors.
more_vert assignment_turned_in Project2020 - 2021Partners:Medicines Discovery Catapult, Medicines Discovery CatapultMedicines Discovery Catapult,Medicines Discovery CatapultFunder: UK Research and Innovation Project Code: EP/V521826/1Funder Contribution: 130,363 GBPAbstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
more_vert